These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years. Farkas H; Kőhalmi KV Expert Rev Clin Immunol; 2018 Jun; 14(6):447-460. PubMed ID: 29757016 [TBL] [Abstract][Full Text] [Related]
37. Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist. Senaratne KT; Cottrell AM; Prentice RI Anaesth Intensive Care; 2012 May; 40(3):523-6. PubMed ID: 22577920 [TBL] [Abstract][Full Text] [Related]
38. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema. Fok JS; Katelaris CH; Brown AF; Smith WB Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565 [TBL] [Abstract][Full Text] [Related]
39. Hereditary angioedema--therapies old and new. Morgan BP N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894 [No Abstract] [Full Text] [Related]
40. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema. Piras V; Alves F; Gonçalo M Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]